Jazz Pharmaceuticals plc (JAZZ): Cash & Equivalents
$1.39B
As of 2025-12-31
$1.62B
As of 2026-06-30
+16.4%
3-year compound annual growth
+5.6%
5-year compound annual growth
+3.5%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.39B | -42.3% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $2.41B | +60.2% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $1.51B | +70.9% | 2025-02-26, Balance as of period end |
| 2022-12-31 | $881.48M | +49.0% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $591.45M | -44.1% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $1.06B | +66.0% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $637.34M | +105.8% | 2021-02-23, Balance as of period end |
| 2018-12-31 | $309.62M | -19.8% | 2020-02-25, Balance as of period end |
| 2017-12-31 | $386.04M | +5.5% | 2019-02-26, Balance as of period end |
| 2016-12-31 | $365.96M | -63.0% | 2019-02-26, Balance as of period end |
| 2015-12-31 | $988.78M | +44.6% | 2018-02-27, Balance as of period end |
| 2014-12-31 | $684.04M | +7.5% | 2017-02-28, Balance as of period end |
| 2013-12-31 | $636.50M | +64.4% | 2016-02-23, Balance as of period end |
| 2012-12-31 | $387.20M | +371.8% | 2015-02-24, Balance as of period end |
| 2011-12-31 | $82.08M | +83.2% | 2014-02-25, Balance as of period end |
| 2010-12-31 | $44.79M | +187.2% | 2013-02-26, Balance as of period end |
| 2009-12-31 | $15.60M | n/a | 2012-02-28, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $1.39B | -42.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $545.00M | +16.5% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $1.66B | +71.5% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.55B | +73.1% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $1.31B | +39.1% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.56B | -8.3% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $282.03M | +155.1% |
| Organon & Co. (OGN) | 2025-12-31 | $574.00M | -15.0% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $618.70M | -33.4% |
Compare JAZZ, ELAN, ALNY, ONC side by side · Screen every company in Pharmaceutical Preparations ↗